Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Terevalefim (ANG-3777) | 1070881-42-3 | 99.9% | 176.24 g/mol | C9H8N2S | 5 MG
SDP

Catalog No. 5000223372
Encompass_Preferred

Terevalefim (ANG-3777) is a small-molecule hepatocyte growth factor (HGF) mimetic that selectively activates the c-Met receptor. It reduces apoptosis, promotes cell proliferation, and has shown efficacy in preclinical models supporting organ repair and function. Intended for research use only.

  • Selectively activates the c-Met receptor.
  • Mimics hepatocyte growth factor activity to reduce apoptosis and promote proliferation.
  • Demonstrated organ repair and functional improvement in animal models.
  • Available as solid and as a DMSO solution for flexible experimental use.
  • High purity suitable for research applications.

Catalog No. 50-002-23372 Supplier Medchemexpress LLC Supplier No. HY1374555MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Terevalefim (ANG-3777) is a small-molecule hepatocyte growth factor (HGF) mimetic that selectively activates the c-Met receptor. It reduces apoptosis, promotes cell proliferation, and has shown efficacy in preclinical models supporting organ repair and function. Intended for research use only.

  • Selectively activates the c-Met receptor.
  • Mimics hepatocyte growth factor activity to reduce apoptosis and promote proliferation.
  • Demonstrated organ repair and functional improvement in animal models.
  • Available as solid and as a DMSO solution for flexible experimental use.
  • High purity suitable for research applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.